Tuesday, February 1, 2011

“ePharma Insights & Rx” Podcast Series 3: Where’s A Good Plumber When You Need One?

Pin It Now!
Je tweet donc je suis…

If 17th century philosopher René Descartes were alive and working in pharma marcomm today, his mantra might well be “I Tweet, therefore I am.”

Or put differently, Twitter has become the plumbing for modern pharma communications: You wouldn’t buy a house without it.

That’s according to Mark Senak, a healthcare public affairs expert with Fleishman-Hillard’s D.C. office and author of the industry leading blog EyeOnFDA.

The problem, of course, is that pipes inevitably clog, and the FDA isn’t much of a plumber.

One might go so far as to suggest that the FDA is, in fact, the source of the clog, but in a plumbing context such a comparison might land yours truly in deep you-know-what.

Instead, I’ll simply note that well-intentioned regulatory policy clearly does not move at the pace of technology. We’re still waiting for FDA’s belated social media draft guidance a month into Q1.

What can be done to clear the clog? Will FDA sit or get off the pot?

In Part Three of our three-part interview for IIR’s podcast series, “ePharma Insights & Prescriptions,” Senak – who is also a lawyer with a healthy interest in pharma regulatory issues – proposes a streamlined, sensible approach to policy process reform in step with speed of Tweet.

We’ll also discuss the rise of “semantic” search and its potential for enabling pharma to partner with the patient in novel, de-risked ways.

To listen to the podcast or download a transcript, please click here.

Author’s note: Mark Senak will be co-conducting a workshop on FDA/DDMAC enforcement trends at IIR’s 10th Annual ePharma Summit on Monday Feb 7.

Don't forget, as a reader of the ePharma Summit blog, you will receive a 10% discount off the current rate when you register using code XP1606BLOG.

Marc Dresner is an IIR communication lead with a background in trade journalism and marketing. He is the former executive editor of Pharma Market Research Report, a confidential newsletter for market researchers in the pharmaceutical industry. He may be reached at mdresner@iirusa.com
Post a Comment